Clinical Trials Directory

Trials / Completed

CompletedNCT02179333

Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University of South Florida · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.

Detailed description

There are few validated, comprehensive rating scales for the assessment of ataxia severity. The development of a Scale To assess Ataxia and Neurologic Dysfunction (STAND) would examine and measure as many facets of ataxia as possible. Scale items to be measured include parkinsonism, timed gait analysis, dystonia, neuropathy and peripheral nerve weakness, as well as other areas of clinical manifestation for ataxia. This brief but thorough scale should yield a thorough measurement of ataxia.

Conditions

Interventions

TypeNameDescription
OTHERAtaxia rating scaleAdminister new rating scale for ataxia. This will be administered by two different raters on two separate occassions, 4 to 6 weeks apart.

Timeline

Start date
2012-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2014-07-01
Last updated
2021-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02179333. Inclusion in this directory is not an endorsement.